PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 9205762

  • 1. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A, Czajkowski A, Skrodzka D, Marlicz K, Luca de Tena F, Aldeguer M, Chantar C, Márquez M, Torres J, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [Abstract] [Full Text] [Related]

  • 2. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
    Matov V, Metchkov G, Krastev Z, Tchernev K, Mitova R, Márquez M, Torres J, Herrero E, Fillat O, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
    [Abstract] [Full Text] [Related]

  • 3. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
    Tulassay Z, Döbrönte Z, Farkas I, Juhász L, Simon L, Prónai L, Torres J, Márquez M.
    Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.
    Gabryelewicz A, Konturek SJ, Butruk E, Dzieniszewski J, Marlicz K, Nowak A, Torres J, Marquez M, Ortiz JA.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):361-6. PubMed ID: 7600143
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
    Puscas I, Puscas C, Coltau M, Pasca R, Torres J, Márquez M, Herrero E, Fillat O, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
    Gedliczka O, Bobrzynski A, Rembiasz K, Fillat O, Torres J, Herrero E, Márquez M, Camps F, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Popiela T, Kulig J, Karcz D, Tabor J, Torres J, Márquez M, Fillat O, Herrero E, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.
    Frías J, Esteban C, Carcas AJ, Sánchez-García P, Albet C, Torres J, Márquez M, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759
    [Abstract] [Full Text] [Related]

  • 9. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers.
    Muñoz-Navas M, Honorato J, Reina-Ariño M, Márquez M, Herrero E, Villamayor F, Torres J, Roset PN, Fíllat O, Camps F, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761
    [Abstract] [Full Text] [Related]

  • 10. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
    Puscas I, Puscas C, Coltau M, Torres J, Márquez M, Herrero E, Fillat O, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
    [Abstract] [Full Text] [Related]

  • 11. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
    Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G.
    Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
    Gilinsky NH, Bright-Asare P, Cobert BL, Fitch DD, Lanza FL, Kerr RM, Savitsky JP.
    Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
    [Abstract] [Full Text] [Related]

  • 13. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D, Romero A, Villamayor F, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [Abstract] [Full Text] [Related]

  • 14. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [Abstract] [Full Text] [Related]

  • 15. Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses.
    Farré M, Roset PN, Badenas JM, Ugena B, Márquez M, Albet C, Herrero E, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):528-30. PubMed ID: 9205758
    [Abstract] [Full Text] [Related]

  • 16. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL, Piotrowski J, Slomiany A.
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [Abstract] [Full Text] [Related]

  • 17. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
    Bovero E, Poletti M, Boero A, Mura BC, Camarri E, Corradini P, Corsini G, Federici G, Curzio M, Gianquinto G.
    Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768
    [Abstract] [Full Text] [Related]

  • 18. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
    Levendoglu H, Mehta B, Wait C, Reddy G, Hatcher C.
    Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 20. Placebo controlled studies with ranitidine in duodenal ulcer.
    Dobrilla G, Barbara L, Bianchi Porro G, Felder M, Mazzacca G, Miglioli L, Pera A, Petrillo M, Sabbatini F, Verme G.
    Scand J Gastroenterol Suppl; 1981 Jun; 69():101-7. PubMed ID: 6119771
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.